The Bertarelli family considered all of the bids for its biotech company Serono too low to entertain, so it has withdrawn its search for a buyer and plans to expand instead by acquiring other firms. Serono, already Europe's largest biotech, is "able to execute a transaction relatively quickly," its chief financial officer said.

Full Story:

Related Summaries